Clinical Trial

A Phase Ia Clinical Trial of HW241045

Name: A Phase Ia Clinical Trial of HW241045 — clinical trial record (NCT07448194)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated March 4, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a Phase Ia, randomized, double-blind, placebo-controlled study to assess the safety, tolerability and pharmacokinetic (PK) of HW241045 in healthy subjects following a single ascending dose.

Trial Details

NCT Number	NCT07448194
Lead Sponsor	Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Conditions	Healthy Volunteers, IPF
Enrollment	56 participants
Start Date	2025-11-24
Primary Completion	2026-06 (estimated)
Study Completion	2026-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-04